References
1. Zhang, J., et al., Resurgence of H5N6 avian influenza virus in
2021 poses new threat to public health. The Lancet Microbe, 2022.
2. Mishin, V.P., et al., Susceptibility of influenza A, B, C, and
D viruses to baloxavir. Emerging infectious diseases, 2019.25 (10): p. 1969.
3. Neumann, G., T. Noda, and Y. Kawaoka, Emergence and pandemic
potential of swine-origin H1N1 influenza virus. Nature, 2009.459 (7249): p. 931-939.
4. Influenza, W.C.o.t.W.C.o.C.A.o.P., Clinical aspects of pandemic
2009 influenza A (H1N1) virus infection. New England Journal of
Medicine, 2010. 362 (18): p. 1708-1719.
5. Reed, C., et al., Estimates of the prevalence of pandemic
(H1N1) 2009, United States, April–July 2009. Emerging infectious
diseases, 2009. 15 (12): p. 2004.
6. Team, N.S.-O.I.A.V.I., Emergence of a novel swine-origin
influenza A (H1N1) virus in humans. New England journal of medicine,
2009. 360 (25): p. 2605-2615.
7. Organization, W.H., Mathematical modelling of the pandemic H1N1
2009. Weekly Epidemiological Record= Relevé épidémiologique
hebdomadaire, 2009. 84 (34): p. 341-348.
8. Investigators, A.I., Critical care services and 2009 H1N1
influenza in Australia and New Zealand. New England Journal of
Medicine, 2009. 361 (20): p. 1925-1934.
9. Louie, J.K., et al., Factors associated with death or
hospitalization due to pandemic 2009 influenza A (H1N1) infection in
California. Jama, 2009. 302 (17): p. 1896-1902.
10. Mauad, T., et al., Lung pathology in fatal novel human
influenza A (H1N1) infection. American journal of respiratory and
critical care medicine, 2010. 181 (1): p. 72-79.
11. Li, P., et al., Serial evaluation of high-resolution CT
findings in patients with pneumonia in novel swine-origin influenza A
(H1N1) virus infection. The British Journal of Radiology, 2012.85 (1014): p. 729-735.
12. Jain, S., et al., Hospitalized patients with 2009 H1N1
influenza in the United States, April–June 2009. New England journal
of medicine, 2009. 361 (20): p. 1935-1944.
13. Vaillant, L., et al., Epidemiology of fatal cases associated
with pandemic H1N1 influenza 2009. Eurosurveillance, 2009.14 (33): p. 19309.
14. Van Kerkhove, M.D., et al., Risk factors for severe outcomes
following 2009 influenza A (H1N1) infection: a global pooled analysis.PLoS medicine, 2011. 8 (7): p. e1001053.
15. Donaldson, L.J., et al., Mortality from pandemic A/H1N1 2009
influenza in England: a public health surveillance study. Bmj, 2009.339 .
16. Flegal, K.M., et al., Excess deaths associated with
underweight, overweight, and obesity. Jama, 2005. 293 (15): p.
1861-1867.
17. Organization, W.H., WHO guidelines for pharmacological
management of pandemic (H1N1) 2009 influenza and other influenza
viruses. 2009.
18. Confalonieri, M., et al., Methylprednisolone infusion for
life-threatening H1N1-virus infection. Therapeutic Advances in
Respiratory Disease, 2010. 4 (4): p. 233-237.
19. Perez-Padilla, R., et al., Pneumonia and respiratory failure
from swine-origin influenza A (H1N1) in Mexico. New England journal of
medicine, 2009. 361 (7): p. 680-689.
20. Organization, W.H., Human infection with new influenza A
(H1N1) virus: clinical observations from Mexico and other affected
countries, May 2009. Weekly Epidemiological Record= Relevé
épidémiologique hebdomadaire, 2009. 84 (21): p. 185-189.
21. Kumar, A., et al., Critically ill patients with 2009 influenza
A (H1N1) infection in Canada. Jama, 2009. 302 (17): p.
1872-1879.
22. Bewick, T., S. Greenwood, and W.S. Lim, What is the role of
pulse oximetry in the assessment of patients with community-acquired
pneumonia in primary care? Primary Care Respiratory Journal, 2010.19 (4): p. 378-382.
23. Hann, H.-W., et al., Comprehensive analysis of common serum
liver enzymes as prospective predictors of hepatocellular carcinoma in
HBV patients. PloS one, 2012. 7 (10): p. e47687.
24. Li, P., et al., Serial evaluation of high-resolution CT
findings in patients with pneumonia in novel swine-origin influenza A
(H1N1) virus infection. The British journal of radiology, 2012.85 (1014): p. 729-735.